News

FDA grants limited approval to new Covid vaccine from Moderna
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
FDA approves Moderna’s new lower-dose COVID-19 vaccine
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
BioSpace4h
FDA Action Alert: Merck, Moderna, Gilead, Regeneron/Sanofi and More
Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir ...
Stocktwits on MSN5h
Moderna’s New COVID Vaccine Gets FDA Green Light; Yet Retail Stays Cautious
Investor sentiment toward Moderna Inc. turned sour during the weekend, despite obtaining FDA authorization for its newest ...
The Washington Post5d
HHS cancels funding for Moderna to develop vaccines to combat bird flu
The Department of Health and Human Services is pulling millions of dollars it had committed to give Moderna to aid the effort to develop a vaccine to combat the bird flu in humans, the company ...
The New York Times4d
U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine
By Apoorva Mandavilli Global health reporter The Trump administration has delivered its latest blow to vaccines, canceling a nearly $600-million contract to the drugmaker Moderna that was intended ...